Troluce Capital Advisors LLC Invests $8.66 Million in Surgery Partners, Inc. (NASDAQ:SGRY)

Troluce Capital Advisors LLC bought a new stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 409,154 shares of the company's stock, valued at approximately $8,662,000. Surgery Partners makes up 0.3% of Troluce Capital Advisors LLC's holdings, making the stock its 6th largest position. Troluce Capital Advisors LLC owned 0.32% of Surgery Partners at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. lifted its holdings in shares of Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after purchasing an additional 465 shares during the period. Wells Fargo & Company MN lifted its holdings in shares of Surgery Partners by 1.4% during the fourth quarter. Wells Fargo & Company MN now owns 56,931 shares of the company's stock worth $1,205,000 after purchasing an additional 783 shares during the period. MeadowBrook Investment Advisors LLC lifted its holdings in shares of Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after purchasing an additional 1,460 shares during the period. KBC Group NV lifted its holdings in shares of Surgery Partners by 66.1% during the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after purchasing an additional 1,577 shares during the period. Finally, Rhumbline Advisers lifted its holdings in shares of Surgery Partners by 1.3% during the fourth quarter. Rhumbline Advisers now owns 121,852 shares of the company's stock worth $2,580,000 after purchasing an additional 1,588 shares during the period.

Surgery Partners Trading Down 2.3%

SGRY stock traded down $0.53 during midday trading on Wednesday, hitting $22.67. The stock had a trading volume of 947,364 shares, compared to its average volume of 1,101,039. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $33.97. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm has a market cap of $2.91 billion, a P/E ratio of -47.23, a price-to-earnings-growth ratio of 19.21 and a beta of 1.96. The business has a fifty day moving average price of $22.53 and a two-hundred day moving average price of $23.11.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $776.00 million during the quarter, compared to the consensus estimate of $777.77 million. During the same period last year, the firm posted $0.10 earnings per share. The company's revenue for the quarter was up 8.2% on a year-over-year basis. On average, sell-side analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Benchmark reiterated a "buy" rating and set a $35.00 price target on shares of Surgery Partners in a report on Monday, April 21st. Royal Bank of Canada restated an "outperform" rating and issued a $35.00 target price on shares of Surgery Partners in a report on Tuesday, March 25th. Finally, Macquarie dropped their target price on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Surgery Partners currently has an average rating of "Moderate Buy" and an average price target of $34.75.

Insider Buying and Selling at Surgery Partners

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the sale, the insider now directly owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. The trade was a 4.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the sale, the chief financial officer now directly owns 150,868 shares of the company's stock, valued at approximately $3,623,849.36. This trade represents a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.30% of the company's stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.